pages/clinical.md
... ...
@@ -9,7 +9,7 @@ link-citations: true
9 9
## Therapeutic targets
10 10
11 11
|Gene|Status|Entity|Therapy|Biomarkers|
12
-|-|-|-|-|:-----:|
12
+|-|-|-|-|:-----|
13 13
|[BCL2](/BCL2)|not approved|DLBCL|venetoclax|Not applicable|
14 14
|[BTK](/BTK#clinical-relevance)|not approved|DLBCL|ibrutinib|ABC gene expression signature, MCD genetic subgroup|
15 15
|[CD79B](/CD79B#clinical-relevance)|FDA approved|DLBCL|polatuzumab vedotin|ABC gene expression signature|